e-learning
resources
Amsterdam 2015
Wednesday, 30.09.2015
Pulmonary hypertension: new treatment insights
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
LATE-BREAKING ABSTRACT: Pulmonary vascular effects after pulsed inhaled NO evaluated by functional respiratory imaging (FRI)
Bita Hajian (Amsterdam, Netherlands), Bita Hajian, Francisca Ferreira, Wim Vos, Jan De Backer, Cedric Van Holsbeke, Douglas Greene, Reinilde Heyrman, Wilfried De Backer
Source:
International Congress 2015 – Pulmonary hypertension: new treatment insights
Session:
Pulmonary hypertension: new treatment insights
Session type:
Oral Presentation
Number:
4993
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Bita Hajian (Amsterdam, Netherlands), Bita Hajian, Francisca Ferreira, Wim Vos, Jan De Backer, Cedric Van Holsbeke, Douglas Greene, Reinilde Heyrman, Wilfried De Backer. LATE-BREAKING ABSTRACT: Pulmonary vascular effects after pulsed inhaled NO evaluated by functional respiratory imaging (FRI). Eur Respir J 2015; 46: Suppl. 59, 4993
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Correlation between cold airway hyperresponsiveness and the content of nitric oxide in the exhaled air in patients with bronchial asthma
Source: International Congress 2014 – Multidimensional analysis of respiratory problems
Year: 2014
Assessment of small airways dysfunction with impulse oscillometry, multiple flow nitric oxide and spirometry in the Wessex severe asthma cohort study
Source: International Congress 2015 – Lung function: waiting to exhale...
Year: 2015
LATE-BREAKING ABSTRACT: Interaction between airway calibre and exhaled NO: the allergen challenge model.
Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Year: 2013
LATE-BREAKING ABSTRACT: Association of free radical formation and respiratory functional parameters in patients with chronic obstructive pulmonary disease: an Electron Paramagnetic Resonance study
Source: International Congress 2014 – Systemic biomarkers for airway diseases
Year: 2014
LATE-BREAKING ABSTRACT: Reference equations for pulmonary diffusing capacity of CO and NO in adult Caucasians
Source: International Congress 2015 – Multidimensional analysis of respiratory problems
Year: 2015
LATE-BREAKING ABSTRACT: Relationships between exhaled nitric oxide and lung function profiles in severe asthma
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013
Role of fractional exhaled nitric oxide(FeNO) in obstructive airway diseases in Indian population
Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease
Year: 2015
LATE-BREAKING ABSTRACT: Extended NO analysis is useful to modify anti-inflammatory treatment in asthmatic children with intermediate FENO50
Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease
Year: 2015
Utility of fractional exhaled nitric oxide (FeNO) in assessing asthma control following inhaled corticosteroid treatment
Source: International Congress 2016 – Assessing lower airway inflammation with different tools
Year: 2016
Temporal stability of feno measurement in COPD
Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease
Year: 2015
Small airway dysfunction and its role in pediatric asthma control assessment
Source: International Congress 2016 – Techniques and tools in paediatric asthma
Year: 2016
Fractional exhaled nitric oxide in chronic obstructive pulmonary disease
Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease
Year: 2015
Interaction between airway calibre and exhaled NO: Impact on asthma control assessment
Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases
Year: 2013
Differential assessment of airway inflammation in chronic obstructive pulmonary disease (COPD) by measurements of exhaled nitric oxide (NO) derived from peripheral
vs.
central airways
Source: Eur Respir J 2003; 22: Suppl. 45, 279s
Year: 2003
Is Fractional exhaled nitric oxide (FeNO) test reliable in the differentiation of chronic obstructive pulmonary disease (COPD) and ACOS (asthma-COPD overlap syndrome)?
Source: International Congress 2017 – Lung function testing in different patient categories
Year: 2017
The experience of monitoring the exhaled nitric oxide (FeNO) during the anti-IgE-therapy (omalizumab) in children with uncontrolled severe asthma
Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease
Year: 2015
Pulsed inhaled nitric oxide (iNO) improves exercise tolerance and shortness of breath (SOB) in severe COPD subjects with pulmonary hypertension (PH)
Source: International Congress 2018 – Advances in exercise physiopathology
Year: 2018
Exhaled nitric oxide in diagnosis and management of respiratory diseases
Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases
Year: 2013
Late Breaking Abstract - Management of asthma in pregnancy using fractional exhaled nitric oxide (FENO) to adjust inhaled corticosteroid (ICS) dose did not improve perinatal outcomes: the Breathing for Life Trial (BLT)
Source: Virtual Congress 2020 – Lung function tests and exhaled biomarkers
Year: 2020
Exhaled NO (FENO50) in COPD - Results from the TIE-study
Source: International Congress 2016 – Inflammatory biomarkers in airway diseases
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept